Skip to content
Menu

IntelGenx Technologies Corp. IGX.TO

Full chart Compare
Set alert

Price alert · IGX.TO

All alert types
0.24 +0.24

Quote time unavailable

Day range unavailable

52-week range unavailable

Market cap
41.92M
Revenue (ttm)
1.05M
Shares out
174.66M
Beta
2.54

 

No chart data for this range yet.

Key statistics

Enterprise value
57.60M
PEG ratio
0.00
Price / sales
39.88
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
7.40%
Free cash flow
-2.98M
Total cash
772.00K
Total debt
16.46M
Return on equity
0.00%
Short % of float
0.01%
50-day average
0.2343
200-day average
0.20765

About IntelGenx Technologies Corp.

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer and Parkinsons; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also develops INT0039/2013 for pain; and INT0053/2020 for the treatment of resistant depression. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on IGX.TO — it syncs with the Stock Master app.

Insider holders

IGX.TO insider holders
InsiderRelationLatest transactionDateShares held
BECHARD ROBERT JOfficerPurchaseJan 21, 201610,000
BOUDREAU BERNARD JDirectorPurchaseMar 31, 2021175,000
BOUDREAU J BERNARDDirectorPurchaseJan 21, 20160
DURHAM JOHN EDWARDOfficerPurchaseOct 6, 201613,000
GODIN ANDREPresidentPurchaseSep 28, 2022308,399
KENNY TOMMYOfficerPurchaseSep 25, 2022138,500